REFERENCES
1. Cassidy SB, Dykens E, Williams CA. Prader-Willi and angelman syndromes: sister imprinted disorders. Am J Med Genet 2000;97:136-46.
2. Butler MG. Prader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics 2011;12:204-15.
4. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001;38:792-8.
5. Yang L, Zhou Q, Ma B, et al. Perinatal features of Prader-Willi syndrome: a Chinese cohort of 134 patients. Orphanet J Rare Dis 2020;15:24.
6. Cheng RQ, Ying YQ, Qiu ZQ, et al. Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome. World J Pediatr 2023;19:438-49.
7. Cheon CK. Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome. Ann Pediatr Endocrinol Metab 2016;21:126-35.
8. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 2015;38:1249-63.
9. Butler MG, Hartin SN, Hossain WA, et al. Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study. J Med Genet 2019;56:149-53.
10. Kim SJ, Miller JL, Kuipers PJ, et al. Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. Eur J Hum Genet 2012;20:283-90.
11. Zhong ML, Chao YQ, Zou CC. Prader-Willi syndrome: molecular mechanism and epigenetic therapy. Curr Gene Ther 2020;20:36-43.
12. Mao S, Yang L, Gao Y, Zou C. Genotype-phenotype correlation in Prader-Willi syndrome: a large-sample analysis in China. Clin Genet 2024;105:415-22.
13. Zhang L, Liu X, Zhao Y, et al. Genetic subtypes and phenotypic characteristics of 110 patients with Prader-Willi syndrome. Ital J Pediatr 2022;48:121.
14. Dang V, Surampalli A, Manzardo AM, et al. Prader-Willi syndrome due to an unbalanced de novo translocation t(15;19)(q12;p13.3). Cytogenet Genome Res 2016;150:29-34.
15. Li Y, Guo H, Zheng J, Jin B. [A neonate Prader-Willi syndrome due to SNORD116 deletion]. Nat Sci 2021;8:1267-9. Available from: http://jnmu.njmu.edu.cn/zr/aumn/article/pdf/aumn210825 [Last accessed on 27 Nov 2024]
16. Anderlid BM, Lundin J, Malmgren H, Lehtihet M, Nordgren A. Small mosaic deletion encompassing the snoRNAs and SNURF-SNRPN results in an atypical Prader-Willi syndrome phenotype. Am J Med Genet A 2014;164A:425-31.
17. Alliende A, Curotto B, Santa Maria L, Cortés F, Aracena M. Prader-Willi syndrome due to 15q11-q13 deletion in a girl with an inherited (13;14) Robertsonian translocation. Am J Med Genet 2002;113:307-8.
18. Cheung SW, Shaffer LG, Richards CS, Page SL, Riconda DL. Prenatal diagnosis of a fetus with a homologous Robertsonian translocation of chromosomes 15. Am J Med Genet 1997;72:47-50.
19. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.
20. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 2001;108:E92.
21. Butler MG, Lee PDK, Whitman BY. Management of Prader-Willi syndrome. New York, NY: Springer; 2006.
22. Grootjen LN, Uyl NEM, van Beijsterveldt IALP, Damen L, Kerkhof GF, Hokken-Koelega ACS. Prenatal and neonatal characteristics of children with Prader-Willi syndrome. J Clin Med 2022;11:679.
23. Gross N, Rabinowitz R, Gross-Tsur V, Hirsch HJ, Eldar-Geva T. Prader-Willi syndrome can be diagnosed prenatally. Am J Med Genet A 2015;167:80-5.
24. Zhou Y, Ma M, Li G, et al. Analysis of the clinical perinatal characteristics of 226 patients with Prader-Willi syndrome in China. Zhonghua Er Ke Za Zhi 2021;59:466-70.
25. Dong GQ, Su YY, Qiu XY, et al. Clinical screening and genetic diagnosis for Prader-Willi syndrome. Zhongguo Dang Dai Er Ke Za Zhi 2020;22:1001-6.
26. Lu A, Luo F, Sun C, Zhang X, Wang L, Lu W. Sleep-disordered breathing and genetic findings in children with Prader-Willi syndrome in China. Ann Transl Med 2020;8:989.
27. Butler MG, Miller JL, Forster JL. Prader-Willi syndrome - clinical genetics, diagnosis and treatment approaches: an update. Curr Pediatr Rev 2019;15:207-44.
28. Soni S, Whittington J, Holland AJ, et al. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. J Intellect Disabil Res 2007;51:32-42.
29. Soni S, Whittington J, Holland AJ, et al. The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome. Psychol Med 2008;38:1505-14.
30. Aman LCS, Manning KE, Whittington JE, Holland AJ. Mechanistic insights into the genetics of affective psychosis from Prader-Willi syndrome. Lancet Psychiat 2018;5:370-8.
31. Li C, Xie B, Shen Y, Luo F. Writing group for practice guidelines for diagnosis and treatment of genetic diseases, Medical genetics branch of Chinese medical association. Clinical practice guidelines for Prader-Willi syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2020;37:318-23.
32. Lin HY, Lin SP, Chuang CK, et al. Genotype and phenotype in patients with Prader-Willi syndrome in Taiwan. Acta Paediatr 2007;96:902-5.
33. Lu W, Qi Y, Cui B, et al. Clinical and genetic features of Prader-Willi syndrome in China. Eur J Pediatr 2014;173:81-6.
34. Yang-Li D, Fei-Hong L, Hui-Wen Z, et al. Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China. Orphanet J Rare Dis 2022;17:221.
35. Bieth E, Eddiry S, Gaston V, et al. Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome. Eur J Hum Genet 2015;23:252-5.
36. Negishi Y, Ieda D, Hori I, et al. Schaaf-Yang syndrome shows a Prader-Willi syndrome-like phenotype during infancy. Orphanet J Rare Dis 2019;14:277.
37. McCarthy J, Lupo PJ, Kovar E, et al. Schaaf-Yang syndrome overview: report of 78 individuals. Am J Med Genet A 2018;176:2564-74.
38. Ge MM, Gao YY, Wu BB, et al. Relationship between phenotype and genotype of 102 Chinese newborns with Prader-Willi syndrome. Mol Biol Rep 2019;46:4717-24.
39. Ehara H, Ohno K, Takeshita K. Frequency of the Prader-Willi syndrome in the San-in district, Japan. Brain Dev 1995;17:324-6.
40. Kim HJ, Cho HJ, Jin DK, et al. Genetic basis of Prader-Willi syndrome in Korea: less uniparental disomy than has been recognized? Clin Genet 2004;66:368-72.
41. Whittington JE, Butler JV, Holland AJ. Changing rates of genetic subtypes of Prader-Willi syndrome in the UK. Eur J Hum Genet 2007;15:127-30.
42. Butler MG, Hedges LK, Rogan PK, Seip JR, Cassidy SB, Moeschler JB. Klinefelter and trisomy X syndromes in patients with Prader-Willi syndrome and uniparental maternal disomy of chromosome 15--a coincidence? Am J Med Genet 1997;72:111-4.
43. Rego A, Coll MD, Regal M, Guitart M, Escudero T, Garcia-Mayor RV. A case with 47,XXY,del(15)(q11;q13) karyotype associated with Prader-Willi phenotype. Horm Res 1997;48:44-6.
44. Verhoeven WM, de Vries BB, Duffels SJ, Egger JI, Noordam C, Tuinier S. Klinefelter's syndrome and Prader-Willi syndrome: a rare combination. Psychopathology 2007;40:356-60.
45. Zou XY, Chao YQ, Zeng LH, Zou CC. Prader-Willi syndrome coincident with DiGeorge syndrome. Indian J Pediatr 2020;87:471-2.
46. Dudley O, Muscatelli F. Clinical evidence of intrauterine disturbance in Prader-Willi syndrome, a genetically imprinted neurodevelopmental disorder. Early Hum Dev 2007;83:471-8.
47. Butler MG, Sturich J, Myers SE, Gold JA, Kimonis V, Driscoll DJ. Is gestation in Prader-Willi syndrome affected by the genetic subtype? J Assist Reprod Genet 2009;26:461-6.
48. Singh P, Mahmoud R, Gold JA, et al. Multicentre study of maternal and neonatal outcomes in individuals with Prader-Willi syndrome. J Med Genet 2018;55:594-8.
49. Whittington JE, Butler JV, Holland AJ. Pre-, peri- and postnatal complications in Prader-Willi syndrome in a UK sample. Early Hum Dev 2008;84:331-6.
50. Salvatoni A, Moretti A, Grugni G, et al. Anthropometric characteristics of newborns with Prader-Willi syndrome. Am J Med Genet A 2019;179:2067-74.
51. Oldzej J, Manazir J, Gold JA, et al. Molecular subtype and growth hormone effects on dysmorphology in Prader-Willi syndrome. Am J Med Genet A 2020;182:169-75.
52. Torrado M, Araoz V, Baialardo E, et al. Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study. Am J Med Genet A 2007;143A:460-8.
53. Holsen LM, Zarcone JR, Chambers R, et al. Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes 2009;33:273-83.
54. Coupaye M, Tauber M, Cuisset L, et al. Effect of genotype and previous GH treatment on adiposity in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 2016;101:4895-903.
55. Schmok T, Surampalli A, Khare M, et al. Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader-Willi syndrome. Am J Med Genet A 2024;194:e63724.
56. Shepherd DA, Vos N, Reid SM, et al. Growth trajectories in genetic subtypes of Prader-Willi syndrome. Genes 2020;11:736.
57. Rosenberg AGW, Wellink CM, Tellez Garcia JM, et al. Health problems in adults with Prader-Willi syndrome of different genetic subtypes: cohort study, meta-analysis and review of the literature. J Clin Med 2022;11:4033.
58. Yu B, Jia S, Gao Y, et al. Analysis of differences in clinical and biochemical characteristics and treatment effects in patients with different genotypes of Prader-Willi syndrome. Zhonghua Yi Xue Za Zhi 2021;101:2760-5.
59. Dykens EM, Cassidy SB, King BH. Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus paternal uniparental disomy. Am J Mental Retard 1999;104:67.
60. Copet P, Jauregi J, Laurier V, et al. Cognitive profile in a large French cohort of adults with Prader-Willi syndrome: differences between genotypes. J Intellect Disabil Res 2010;54:204-15.
61. Dimitropoulos A, Ferranti A, Lemler M. Expressive and receptive language in Prader-Willi syndrome: report on genetic subtype differences. J Commun Disord 2013;46:193-201.
62. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;359:135-6.
63. Montes AS, Osann KE, Gold JA, et al. Genetic subtype-phenotype analysis of growth hormone treatment on psychiatric behavior in Prader-Willi syndrome. Genes 2020;11:1250.
64. Thuilleaux D, Laurier V, Copet P, et al. A model to characterize psychopathological features in adults with Prader-Willi syndrome. Am J Med Genet A 2018;176:41-7.
65. Shriki-Tal L, Avrahamy H, Pollak Y, et al. Psychiatric disorders in a cohort of individuals with Prader-Willi syndrome. Eur Psychiatry 2017;44:47-52.
66. Manzardo AM, Weisensel N, Ayala S, Hossain W, Butler MG. Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults. Clin Genet 2018;93:622-31.
67. Aman LCS, Lester SD, Holland AJ, Fletcher PC. Psychotic illness in people with Prader-Willi syndrome: a systematic review of clinical presentation, course and phenomenology. Orphanet J Rare Dis 2024;19:69.
68. Vogels A, Matthijs G, Legius E, Devriendt K, Fryns JP. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome. J Med Genet 2003;40:72-3.
69. Holland AJ, Whittington JE, Butler J, Webb T, Boer H, Clarke D. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome. Psychol Med 2003;33:141-53.
70. Whittington J, Holland A. A review of psychiatric conceptions of mental and behavioural disorders in Prader-Willi syndrome. Neurosci Biobehav Rev 2018;95:396-405.
71. Yang L, Zhan GD, Ding JJ, et al. Psychiatric illness and intellectual disability in the Prader-Willi syndrome with different molecular defects-a meta analysis. PLoS One 2013;8:e72640.
72. Sinnema M, Boer H, Collin P, et al. Psychiatric illness in a cohort of adults with Prader-Willi syndrome. Res Dev Disabil 2011;32:1729-35.
73. Lo ST, Collin PJ, Hokken-Koelega AC. Psychiatric disorders in children with Prader-Willi syndrome-results of a 2-year longitudinal study. Am J Med Genet A 2015;167A:983-91.
74. Feighan SM, Hughes M, Maunder K, Roche E, Gallagher L. A profile of mental health and behaviour in Prader-Willi syndrome. J Intellect Disabil Res 2020;64:158-69.
75. Bennett JA, Germani T, Haqq AM, Zwaigenbaum L. Autism spectrum disorder in Prader-Willi syndrome: a systematic review. Am J Med Genet A 2015;167A:2936-44.
76. Veltman MW, Craig EE, Bolton PF. Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review. Psychiatr Genet 2005;15:243-54.
77. Veltman MW, Thompson RJ, Roberts SE, Thomas NS, Whittington J, Bolton PF. Prader-Willi syndrome-a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders. Eur Child Adolesc Psychiatry 2004;13:42-50.
78. Milner KM, Craig EE, Thompson RJ, et al. Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry 2005;46:1089-96.
79. Victor AK, Donaldson M, Johnson D, Miller W, Reiter LT. Molecular changes in Prader-Willi syndrome neurons reveals clues about increased autism susceptibility. Front Mol Neurosci 2021;14:747855.
80. Mahmoud R, Swanson HD, Butler MG, et al. Molecular classes and growth hormone treatment effects on behavior and emotion in patients with Prader-Willi syndrome. J Clin Med 2022;11:2572.
81. Zarcone J, Napolitano D, Peterson C, et al. The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. J Intellect Disabil Res 2007;51:478-87.
82. Hartley SL, Maclean WE Jr, Butler MG, Zarcone J, Thompson T. Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome. Am J Med Genet A 2005;136:140-5.
83. Dimitropoulos A, Doernberg EA, Russ SW, Zyga O. Intervention response by genetic subtype: PRETEND-preschool program for children with Prader-Willi syndrome via remote parent training. J Autism Dev Disord 2022;52:5191-206.
84. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 2004;113:565-73.
85. Honea RA, Holsen LM, Lepping RJ, et al. The neuroanatomy of genetic subtype differences in Prader-Willi syndrome. Am J Med Genet B Neuropsychiatr Genet 2012;159B:243-53.
86. Lukoshe A, White T, Schmidt MN, van der Lugt A, Hokken-Koelega AC. Divergent structural brain abnormalities between different genetic subtypes of children with Prader-Willi syndrome. J Neurodev Disord 2013;5:31.
87. Butler MG, Nelson TA, Driscoll DJ, Manzardo AM. High plasma neurotensin levels in children with Prader-Willi syndrome. Am J Med Genet A 2015;167A:1773-8.
88. Kleczkowska P, Lipkowski AW. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation-a review. Eur J Pharmacol 2013;716:54-60.
89. Key AP, Jones D, Dykens EM. Social and emotional processing in Prader-Willi syndrome: genetic subtype differences. J Neurodev Disord 2013;5:7.
90. Crinò A, Schiaffini R, Ciampalini P, et al. Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr 2003;162:327-33.
91. Pellikaan K, Ben Brahim Y, Rosenberg AGW, et al. Hypogonadism in women with Prader-Willi syndrome-clinical recommendations based on a dutch cohort study, review of the literature and an international expert panel discussion. J Clin Med 2021;10:5781.
92. de Lind van Wijngaarden RFA, Otten BJ, Festen DAM, et al. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2008;93:1649-54.
93. Grugni G, Beccaria L, Corrias A, et al. Central adrenal insufficiency in young adults with Prader-Willi syndrome. Clin Endocrinol 2013;79:371-8.
94. Obrynba KS, Hoffman RP, Repaske DR, Anglin K, Kamboj MK. No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test. J Pediatr Endocrinol Metab 2018;31:809-14.
95. Angulo MA, Butler MG, Hossain WA, Castro-Magana M, Corletto J. Central adrenal insufficiency screening with morning plasma cortisol and ACTH levels in Prader-Willi syndrome. J Pediatr Endocrinol Metab 2022;35:733-40.
96. Butler MG, Brandau DT, Theodoro M, Garg U. Cortisol levels in Prader-Willi syndrome support changes in routine care. Am J Med Genet A 2009;149A:138-9.
97. Corrias A, Grugni G, Crinò A, et al. Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. Clin Endocrinol 2012;76:843-50.
98. Oto Y, Matsubara K, Ayabe T, et al. Delayed peak response of cortisol to insulin tolerance test in patients with Prader-Willi syndrome. Am J Med Genet A 2018;176:1369-74.
99. Bocchini S, Fintini D, Grugni G, Boiani A, Convertino A, Crinò A. Congenital hypothyroidism due to ectopic sublingual thyroid gland in Prader-Willi syndrome: a case report. Ital J Pediatr 2017;43:87.
100. Wong K, Levitsky LL, Misra M. Predictors and growth consequences of central hypothyroidism in pediatric patients receiving recombinant human growth hormone. J Pediatr Endocrinol Metab 2010;23:451-61.
101. Savopoulos C, Hatzitolios A, Panagopoulou P, Kosmidou M, Tsirogianni E, Konstantinou V. Hypothyroidism in Prader-Willi syndrome: a case report and review of the literature. J Endocrinol Invest 2007;30:804-5.
102. Grugni G, Giardino D, Crinò A, et al. Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes. J Endocrinol Invest 2011;34:493-7.
103. Alves C, Franco RR. Prader-Willi syndrome: endocrine manifestations and management. Arch Endocrinol Metab 2020;64:223-34.
104. Di Giorgio G, Grugni G, Fintini D, et al. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome. Horm Res Paediatr 2014;81:189-95.
105. Marostica E, Grugni G, De Nicolao G, et al. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences. Growth Horm IGF Res 2013;23:261-6.
106. Grugni G, Crinò A, Pagani S, et al. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2011;24:477-81.
107. Grugni G, Sartorio A, Crinò A. Growth hormone therapy for Prader-willi syndrome: challenges and solutions. Ther Clin Risk Manag 2016;12:873-81.
108. Oto Y, Obata K, Matsubara K, et al. Growth hormone secretion and its effect on height in pediatric patients with different genotypes of Prader-Willi syndrome. Am J Med Genet A 2012;158A:1477-80.
109. Grugni G, Marostica E, Crinò A, Marzullo P, De Nicolao G, Sartorio A. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls. Clin Endocrinol 2013;79:224-31.
110. Gao Y, Yang LL, Dai YL, Shen Z, Zhou Q, Zou CC. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome. Orphanet J Rare Dis 2023;18:25.
111. Gil E, Giménez-Palop O, Caixàs A. Treatment with growth hormone in the Prader-Willi syndrome. Endocrinol Diabetes Nutr 2018;65:229-36.
112. Butler MG, Matthews NA, Patel N, et al. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index. Am J Med Genet A 2019;179:1826-35.
113. Forster J, Duis J, Butler MG. Pharmacogenetic testing of cytochrome P450 drug metabolizing enzymes in a case series of patients with Prader-Willi syndrome. Genes 2021;12:152.
114. Mahmoud R, Leonenko A, Butler MG, et al. Influence of molecular classes and growth hormone treatment on growth and dysmorphology in Prader-Willi syndrome: a multicenter study. Clin Genet 2021;100:29-39.
115. Pacoricona Alfaro DL, Lemoine P, Ehlinger V, et al. Causes of death in Prader-Willi syndrome: lessons from 11 years’ experience of a national reference center. Orphanet J Rare Dis 2019;14:238.
116. Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader-Willi Syndrome: a systematic review of studies of morbidity and mortality. Eur J Med Genet 2022;65:104379.
117. Butler MG, Manzardo AM, Heinemann J, Loker C, Loker J. Causes of death in Prader-Willi syndrome: Prader-Willi syndrome association (USA) 40-year mortality survey. Genet Med 2017;19:635-42.
118. Peleggi A, Bohonowych J, Strong TV, Schwartz L, Kim SJ. Suicidality in individuals with Prader-Willi syndrome: a review of registry survey data. BMC Psychiatry 2021;21:438.
119. Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 2011;130:517-28.
120. Butler MG. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder. J Intellect Disabil Res 2017;61:568-79.
121. Novell-Alsina R, Esteba-Castillo S, Caixas A, et al. Compulsions in Prader-Willi syndrome: occurrence and severity as a function of genetic subtype. Actas Esp Psiquiatr 2019;47:79-87.
122. Dykens EM, Roof E. Behavior in Prader-Willi syndrome: relationship to genetic subtypes and age. J Child Psychol Psychiatry 2008;49:1001-8.
123. Correa-da-Silva F, Carter J, Wang XY, et al. Microglial phagolysosome dysfunction and altered neural communication amplify phenotypic severity in Prader-Willi Syndrome with larger deletion. Acta Neuropathol 2024;147:64.
124. Butler MG, Cowen N, Bhatnagar A. Prader-Willi syndrome, deletion subtypes, and magnesium: potential impact on clinical findings. Am J Med Genet A 2022;188:3278-86.
125. Bakker NE, Lindberg A, Heissler J, Wollmann HA, Camacho-Hübner C, Hokken-Koelega AC. KIGS Steering Committee. Growth hormone treatment in children with Prader-Willi syndrome: three years of longitudinal data in prepubertal children and adult height data from the KIGS database. J Clin Endocrinol Metab 2017;102:1702-11.
